{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:34:33Z","timestamp":1788280473824,"version":"build-2803163510"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Neurofibromatosis type 2 (NF2) is characterized by bilateral vestibular schwannomas, and approximately 40\u201370% of affected children show ophthalmological involvement. Ophthalmological features may be the first sign of NF2; however, the symptoms associated with ocular lesions are diverse. The onset of NF2 is often obscure, resulting in missed or misdiagnosed cases. Herein, we report a case of NF2 in a child who initially presented with poor eyesight. The child had been treated for amblyopia for 7\u202fyears and was referred to the eye oncology department due to a lack of improvement in vision. At birth, a soft mass was noted scattered across the abdominal skin and scalp, which gradually increased in size over time. Ophthalmological examination revealed posterior subcapsular opacity in the right eye and an anterior retinal hamartoma in the left eye. Orbital and cranial magnetic resonance imaging (MRI) indicated that the T1 and T2 signals of multiple structures, including the cone, auditory nerve, trigeminal nerve, left oculomotor nerve, paravertebral, and sublingual region, were more uniform after enhancement. A genetic heterozygous mutation was detected, with no family history of the condition. In addition to this case, we collected and summarized 158 publicly reported cases of NF2 with ophthalmological characteristics. Among these cases, the incidence of visual impairment, strabismus, cataract, retinal anomaly, and retinal hamartoma was high, reaching 64, 38, 25, 23, and 16%, respectively. Through analysis and discussion of the clinical and imaging characteristics of NF2 ocular lesions, we aim to improve ophthalmologists\u2019 understanding of this disease, thereby reducing the rate of missed diagnoses.<\/jats:p>","DOI":"10.3389\/fmed.2025.1556494","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T05:29:30Z","timestamp":1754544570000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Neurofibromatosis type 2 misdiagnosed as amblyopia\u2014a case report and literature review"],"prefix":"10.3389","volume":"12","author":[{"given":"Qian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.otc.2023.02.012","article-title":"Management of neurofibromatosis type 2-associated vestibular schwannomas","volume":"56","author":"Jiramongkolchai","year":"2023","journal-title":"Otolaryngol Clin N Am"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/adc.81.6.496","article-title":"Paediatric presentation of type 2 neurofibromatosis","volume":"81","author":"Evans","year":"1999","journal-title":"Arch Dis Child"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13023-022-02379-6","article-title":"Dermatologic manifestations in paediatric neurofibromatosis type 2: a cross sectional descriptive multicentric study","volume":"17","author":"Legoupil","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"ref4","article-title":"2-related schwannomatosis. NF, in GeneReviews","volume-title":"University of Washington, Seattle. Copyright \u00a9 1993\u20132024. GeneReviews is a registered trademark of the","author":"Evans","year":"1993"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/archdischild-2017-313154","article-title":"Diagnosis of sporadic neurofibromatosis type 2 in the paediatric population","volume":"103","author":"Anand","year":"2018","journal-title":"Arch Dis Child"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e710","DOI":"10.1097\/rlu.0000000000004355","article-title":"Neurofibromatosis type 2: multiple meningiomatosis and vestibular schwannomas on 68 ga-dotatate PET\/CT","volume":"47","author":"Filizoglu","year":"2022","journal-title":"Clin Nucl Med"},{"key":"ref7","first-page":"393","article-title":"Case of tumours in the skull, dura mater, and brain","volume":"18","author":"Wishart","year":"1822","journal-title":"Edinb Med Surg J"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e529","DOI":"10.1097\/mao.0000000000002613","article-title":"Genomics, epigenetics, and hearing loss in neurofibromatosis type 2","volume":"41","author":"Dinh","year":"2020","journal-title":"Otol Neurotol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-019-02029-5","article-title":"An update on the CNS manifestations of neurofibromatosis type 2","volume":"139","author":"Coy","year":"2020","journal-title":"Acta Neuropathol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/gcc.22232","article-title":"Genome-wide methylation analysis in vestibular schwannomas shows putative mechanisms of gene expression modulation and global hypomethylation at the HOX gene cluster","volume":"54","author":"Torres-Mart\u00edn","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","article-title":"Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation","volume":"24","author":"Plotkin","year":"2022","journal-title":"Genet Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"p:vdaa153","DOI":"10.1093\/noajnl\/vdaa153","article-title":"New developments in neurofibromatosis type 2 and vestibular schwannoma","volume":"3","author":"Ren","year":"2021","journal-title":"Neurooncol Adv"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.neuchi.2015.03.012","article-title":"Natural history of vestibular schwannomas and hearing loss in NF2 patients","volume":"64","author":"Peyre","year":"2018","journal-title":"Neurochirurgie"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3171\/spi.2005.2.5.0574","article-title":"Spinal tumors in neurofibromatosis type 2. Is emerging knowledge of genotype predictive of natural history?","volume":"2","author":"Dow","year":"2005","journal-title":"J Neurosurg Spine"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/02688697.2020.1836323","article-title":"What to know about schwannomatosis: a literature review","volume":"36","author":"Schraepen","year":"2022","journal-title":"Br J Neurosurg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"12563","DOI":"10.1038\/s41598-020-69074-z","article-title":"Comparative clinical and genomic analysis of neurofibromatosis type 2-associated cranial and spinal meningiomas","volume":"10","author":"Pemov","year":"2020","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11060-010-0339-x","article-title":"Meningiomas and neurofibromatosis","volume":"99","author":"Goutagny","year":"2010","journal-title":"J Neuro-Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5693\/djo.02.2021.06.001","article-title":"Surgical outcome and pathological findings in macular epiretinal membrane caused by neurofibromatosis type 2","volume":"28","author":"Kunikata","year":"2022","journal-title":"Digit J Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/icb.0000000000000630","article-title":"A case of neurofibromatosis TYPE 2 with unusual clinical features","volume":"14","author":"Zarei","year":"2020","journal-title":"Retin Cases Brief Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"614","DOI":"10.16636\/j.cnki.jinn.2020.06.009","article-title":"A new case of type 2 neurofibroma disease and literature analysis","volume":"47","author":"Luowen","year":"2020","journal-title":"Int J Neurosurg"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jamaophthalmol.2018.7176","article-title":"A young girl with bilateral atypical epiretinal membranes","volume":"137","author":"Giovinazzo","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s00417-019-04348-5","article-title":"Ocular alterations, molecular findings, and three novel pathological mutations in a series of NF2 patients","volume":"257","author":"Waisberg","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"614","DOI":"10.16636\/j.cnki.jinn.2018.06.016","article-title":"A case of comprehensive treatment of juvenile neurofibroma disease type II was reported","volume":"45","author":"Kang","year":"2018","journal-title":"Int J Neurosurg"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"18919","DOI":"10.1167\/iovs.15-18919","article-title":"Spectral-domain optical coherence tomography findings in neurofibromatosis type 2","volume":"57","author":"Waisberg","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/wno.0000000000000279","article-title":"Cilioretinal artery territory infarction associated with papilledema in a patient with neurofibromatosis type 2","volume":"36","author":"Mahroo","year":"2016","journal-title":"J Neuroophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.spen.2015.10.008","article-title":"Diagnosis, management, and new therapeutic options in childhood neurofibromatosis type 2 and related forms","volume":"22","author":"Ruggieri","year":"2015","journal-title":"Semin Pediatr Neurol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1001\/archophthalmol.2012.2305","article-title":"Surgical removal of an atypical macular epiretinal membrane in neurofibromatosis type 2: Clinicopathologic correlation and visual outcome","volume":"130","author":"Han","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/j.1600-0420.2007.01088.x","article-title":"Neurofibromatosis 2 leads to higher incidence of strabismological and neuro-ophthalmological disorders","volume":"86","author":"Feucht","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/00006982-200510000-00019","article-title":"Neurofibromatosis type 2 in an infant presenting with visual impairment confirmed by genetic mutation analysis","volume":"25","author":"Kim","year":"2005","journal-title":"Retina"},{"key":"ref30","first-page":"471","article-title":"Four cases of neurofibromatosis type II","volume":"5","author":"Lihua","year":"2005","journal-title":"Chin J Ophthalmol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1055\/s-2004-812817","article-title":"Multiple intraorbital neurofibromas: a rare cause of proptosis","volume":"221","author":"Berney","year":"2004","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/eye.1997.3","article-title":"The ocular presentation of neurofibromatosis 2","volume":"11","author":"Ragge","year":"1997","journal-title":"Eye"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/s0039-6257(96)80003-8","article-title":"Blindness, deafness, quadriparesis, and a retinal malformation: the ravages of neurofibromatosis 2","volume":"41","author":"Rettele","year":"1996","journal-title":"Surv Ophthalmol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/s0002-9394(14)70558-6","article-title":"Retinal changes associated with neurofibromatosis 2","volume":"93","author":"Meyers","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3341\/kjo.2013.27.1.68","article-title":"Spectral-domain optical coherence tomography of combined hamartoma of the retina and retinal pigment epithelium in neurofibromatosis","volume":"27","author":"Kang","year":"2013","journal-title":"Korean J Ophthalmol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000519143","article-title":"Structural abnormalities of the central retina in neurofibromatosis type 2","volume":"65","author":"Emmanouil","year":"2022","journal-title":"Ophthal Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00347-016-0237-5","article-title":"Augenbeteiligung bei Neurofibromatose","volume":"113","author":"Baier","year":"2016","journal-title":"Ophthalmologe"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.otc.2015.02.005","article-title":"Neurofibromatosis type 2","volume":"48","author":"Slattery","year":"2015","journal-title":"Otolaryngol Clin N Am"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1024\/1661-8157\/a00442","article-title":"The lazy eye - contemporary strategies of amblyopia treatment","volume":"4","year":"2011","journal-title":"Praxis"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3760\/cma.j.cn112142-20210109-00014","article-title":"Expert consensus on the prevention and treatment of amblyopia in children in China (2021)","volume":"57","year":"2021","journal-title":"Chin J Ophthalmol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.4103\/ijo.Ijo_338_23","article-title":"Comprehensive review of amblyopia: types and management","volume":"71","author":"Kaur","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"ref42","first-page":"562","article-title":"A case of congenital macular abnormal blood vessels misdiagnosed as amblyopia","volume":"30","author":"Yanli","year":"2022","journal-title":"J Clin Ophthalmol"},{"key":"ref43","first-page":"35","article-title":"Two cases of children\u2019s brain-borne visual impairment were misdiagnosed as amblyopia","volume":"28","author":"Cong","year":"2020","journal-title":"Chin J Strabismus Pediatr Ophthalmol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10792-012-9600-y","article-title":"Foveal retinoschisis misdiagnosed as bilateral amblyopia","volume":"32","author":"Kyung","year":"2012","journal-title":"Int Ophthalmol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1370\/afm.193","article-title":"Screening for visual impairment in children younger than age 5 years: recommendation statement","volume":"2","year":"2004","journal-title":"Ann Fam Med"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s40487-024-00279-2","article-title":"Gene therapy for Neurofibromatosis type 2-related Schwannomatosis: recent Progress, challenges, and future directions","volume":"12","author":"Yuan","year":"2024","journal-title":"Oncol Ther"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/neuonc\/nov200","article-title":"Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis","volume":"18","author":"Blakeley","year":"2016","journal-title":"Neuro-Oncology"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1556494\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T05:29:35Z","timestamp":1754544575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1556494\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":47,"alternative-id":["10.3389\/fmed.2025.1556494"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1556494","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"article-number":"1556494"}}